References
- Mandelkow EM and Mandelkow E (1998) Tau in Alzheimer's disease. Trends Cell Biol 8, 425-427 https://doi.org/10.1016/S0962-8924(98)01368-3
- Andreadis A (2006) Misregulation of tau alternative splicing in neurodegeneration and dementia. Prog Mol Subcell Biol 44, 89-107
- Goedert M, Spillantini MG, Jakes R, Rutherford D and Crowther RA (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519-526 https://doi.org/10.1016/0896-6273(89)90210-9
- Goedert M, Cohen ES, Jakes R and Cohen P (1992) p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1. Implications for Alzheimer's disease [corrected]. FEBS Lett 312, 95-99 https://doi.org/10.1016/0014-5793(92)81418-L
- Kyte J and Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157, 105-132 https://doi.org/10.1016/0022-2836(82)90515-0
- Alonso AD, Zaidi T, Novak M, Barra HS, Grundke-Iqbal I and Iqbal K (2001) Interaction of tau isoforms with Alzheimer's disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein. J Biol Chem 276, 37967-37973
- Wolfe MS (2009) Tau mutations in neurodegenerative diseases. J Biol Chem 284, 6021-6025 https://doi.org/10.1074/jbc.R800013200
- Abraha A, Ghoshal N, Gamblin TC et al (2000) C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease. J Cell Sci 113 Pt 21, 3737-3745
- Flores-Rodriguez P, Ontiveros-Torres MA, Cardenas-Aguayo MC et al (2015) The relationship between truncation and phosphorylation at the C-terminus of tau protein in the paired helical filaments of Alzheimer's disease. Front Neurosci 9, 33
- Peeraer E, Bottelbergs A, Van Kolen K et al (2015) Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice. Neurobiol Dis 73, 83-95 https://doi.org/10.1016/j.nbd.2014.08.032
- Guo JL and Lee VM (2013) Neurofibrillary tangle-like tau pathology induced by synthetic tau fibrils in primary neurons over-expressing mutant tau. FEBS Lett 587, 717-723 https://doi.org/10.1016/j.febslet.2013.01.051
- Guo JL and Lee VM (2011) Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem 286, 15317-15331 https://doi.org/10.1074/jbc.M110.209296
- Nubling G, Bader B, Levin J, Hildebrandt J, Kretzschmar H and Giese A (2012) Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with alpha-synuclein at the single molecule level. Mol Neurodegener 7, 35 https://doi.org/10.1186/1750-1326-7-35
- Choi TS, Lee J, Han JY et al (2018) Supramolecular Modulation of Structural Polymorphism in Pathogenic alpha-Synuclein Fibrils Using Copper(II) Coordination. Angew Chem Int Ed Engl 57, 3099-3103 https://doi.org/10.1002/anie.201712286
- Wille H, Drewes G, Biernat J, Mandelkow EM and Mandelkow E (1992) Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro. J Cell Biol 118, 573-584 https://doi.org/10.1083/jcb.118.3.573
- Fitzpatrick AWP, Falcon B, He S et al (2017) Cryo-EM structures of tau filaments from Alzheimer's disease. Nature 547, 185-190 https://doi.org/10.1038/nature23002
- Giannakopoulos P, Herrmann FR, Bussiere T et al (2003) Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 60, 1495-1500 https://doi.org/10.1212/01.WNL.0000063311.58879.01
- Ethell DW (2010) An amyloid-notch hypothesis for Alzheimer's disease. Neuroscientist 16, 614-617 https://doi.org/10.1177/1073858410366162
- Hung SY and Fu WM (2017) Drug candidates in clinical trials for Alzheimer's disease. J Biomed Sci 24, 47 https://doi.org/10.1186/s12929-017-0355-7
- Wang Y and Mandelkow E (2016) Tau in physiology and pathology. Nat Rev Neurosci 17, 5-21 https://doi.org/10.1038/nrg.2015.11
- Min SW, Cho SH, Zhou Y et al (2010) Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron 67, 953-966 https://doi.org/10.1016/j.neuron.2010.08.044
- Roth SY, Denu JM and Allis CD (2001) Histone acetyltransferases. Annu Rev Biochem 70, 81-120 https://doi.org/10.1146/annurev.biochem.70.1.81
- Liu X, Wang L, Zhao K et al (2008) The structural basis of protein acetylation by the p300/CBP transcriptional coactivator. Nature 451, 846-850 https://doi.org/10.1038/nature06546
- Marmorstein R (2001) Structure of histone acetyltransferases. J Mol Biol 311, 433-444 https://doi.org/10.1006/jmbi.2001.4859
- Cohen TJ, Guo JL, Hurtado DE et al (2011) The acetylation of tau inhibits its function and promotes pathological tau aggregation. Nat Commun 2, 252 https://doi.org/10.1038/ncomms1255
- Morris M, Knudsen GM, Maeda S et al (2015) Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice. Nat Neurosci 18, 1183-1189 https://doi.org/10.1038/nn.4067
- Cook C, Carlomagno Y, Gendron TF et al (2014) Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance. Hum Mol Genet 23, 104-116 https://doi.org/10.1093/hmg/ddt402
- Ding H, Dolan PJ and Johnson GV (2008) Histone deacetylase 6 interacts with the microtubule-associated protein tau. J Neurochem 106, 2119-2130 https://doi.org/10.1111/j.1471-4159.2008.05564.x
- Fan SJ, Huang FI, Liou JP, Yang CR (2018) The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model. Cell Death Dis 9, 655 https://doi.org/10.1038/s41419-018-0688-5
- Carlomagno Y, Chung DC, Yue M et al (2017) An acetylation-phosphorylation switch that regulates tau aggregation propensity and function. J Biol Chem 292, 15277-15286 https://doi.org/10.1074/jbc.M117.794602
- Julien C, Tremblay C, Emond V et al (2009) Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol 68, 48-58 https://doi.org/10.1097/NEN.0b013e3181922348
- Gorsky MK, Burnouf S, Sofola-Adesakin O et al (2017) Pseudo-acetylation of multiple sites on human Tau proteins alters Tau phosphorylation and microtubule binding, and ameliorates amyloid beta toxicity. Sci Rep 7, 9984 https://doi.org/10.1038/s41598-017-10225-0
- Min SW, Chen X, Tracy TE et al (2015) Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits. Nat Med 21, 1154-1162 https://doi.org/10.1038/nm.3951
- Tracy TE, Sohn PD, Minami SS et al (2016) Acetylated Tau Obstructs KIBRA-Mediated Signaling in Synaptic Plasticity and Promotes Tauopathy-Related Memory Loss. Neuron 90, 245-260 https://doi.org/10.1016/j.neuron.2016.03.005
- Irwin DJ, Cohen TJ, Grossman M et al (2013) Acetylated tau neuropathology in sporadic and hereditary tauopathies. Am J Pathol 183, 344-351 https://doi.org/10.1016/j.ajpath.2013.04.025
- Trzeciakiewicz H, Tseng JH, Wander CM et al (2017) A Dual Pathogenic Mechanism Links Tau Acetylation to Sporadic Tauopathy. Sci Rep 7, 44102 https://doi.org/10.1038/srep44102
- Gorsky MK, Burnouf S, Dols J, Mandelkow E and Partridge L (2016) Acetylation mimic of lysine 280 exacerbates human Tau neurotoxicity in vivo. Sci Rep 6, 22685 https://doi.org/10.1038/srep22685
- Irwin DJ, Cohen TJ, Grossman M et al (2012) Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies. Brain 135, 807-818 https://doi.org/10.1093/brain/aws013
- Luo Y, Ma B, Nussinov R and Wei G (2014) Structural Insight into Tau Protein's Paradox of Intrinsically Disordered Behavior, Self-Acetylation Activity, and Aggregation. J Phys Chem Lett 5, 3026-3031 https://doi.org/10.1021/jz501457f
- Santa-Maria I, Hernandez F, Martin CP, Avila J and Moreno FJ (2004) Quinones facilitate the self-assembly of the phosphorylated tubulin binding region of tau into fibrillar polymers. Biochemistry 43, 2888-2897 https://doi.org/10.1021/bi035345j
- Perez M, Hernandez F, Lim F, Diaz-Nido J and Avila J (2003) Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model. J Alzheimers Dis 5, 301-308 https://doi.org/10.3233/JAD-2003-5405
- Noble W, Planel E, Zehr C et al (2005) Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci U S A 102, 6990-6995 https://doi.org/10.1073/pnas.0500466102
- Avila J (2006) Tau phosphorylation and aggregation in Alzheimer's disease pathology. FEBS Lett 580, 2922-2927 https://doi.org/10.1016/j.febslet.2006.02.067
- Kopke E, Tung YC, Shaikh S, Alonso AC, Iqbal K and Grundke-Iqbal I (1993) Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem 268, 24374-24384
- Kenessey A and Yen SH (1993) The extent of phosphorylation of fetal tau is comparable to that of PHF-tau from Alzheimer paired helical filaments. Brain Res 629, 40-46 https://doi.org/10.1016/0006-8993(93)90478-6
- Lee G, Thangavel R, Sharma VM et al (2004) Phosphorylation of tau by fyn: implications for Alzheimer's disease. J Neurosci 24, 2304-2312 https://doi.org/10.1523/JNEUROSCI.4162-03.2004
- Braak E, Braak H and Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87, 554-567 https://doi.org/10.1007/BF00293315
- Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R and Avila J (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J 20, 27-39 https://doi.org/10.1093/emboj/20.1.27
- Forlenza OV, Aprahamian I, de Paula VJ and Hajek T (2016) Lithium, a Therapy for AD: Current Evidence from Clinical Trials of Neurodegenerative Disorders. Curr Alzheimer Res 13, 879-886 https://doi.org/10.2174/1567205013666160219112854
- King MK, Pardo M, Cheng Y, Downey K, Jope RS and Beurel E (2014) Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments. Pharmacol Ther 141, 1-12 https://doi.org/10.1016/j.pharmthera.2013.07.010
- Matsunaga S, Kishi T, Annas P, Basun H, Hampel H and Iwata N (2015) Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-Analysis. J Alzheimers Dis 48, 403-410 https://doi.org/10.3233/JAD-150437
- Yu Y, Run X, Liang Z et al (2009) Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases. J Neurochem 108, 1480-1494 https://doi.org/10.1111/j.1471-4159.2009.05882.x
- Noble W, Hanger DP, Miller CC and Lovestone S (2013) The importance of tau phosphorylation for neurodegenerative diseases. Front Neurol 4, 83
- Sontag JM and Sontag E (2014) Protein phosphatase 2A dysfunction in Alzheimer's disease. Front Mol Neurosci 7, 16
- Liu F, Grundke-Iqbal I, Iqbal K and Gong CX (2005) Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neurosci 22, 1942-1950 https://doi.org/10.1111/j.1460-9568.2005.04391.x
- Gong CX, Shaikh S, Wang JZ, Zaidi T, Grundke-Iqbal I and Iqbal K (1995) Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J Neurochem 65, 732-738
- Gong CX, Singh TJ, Grundke-Iqbal I and Iqbal K (1993) Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 61, 921-927 https://doi.org/10.1111/j.1471-4159.1993.tb03603.x
- Choi WH, de Poot SA, Lee JH et al (2016) Open-gate mutants of the mammalian proteasome show enhanced ubiquitin-conjugate degradation. Nat Commun 7, 10963 https://doi.org/10.1038/ncomms10963
- Han DH, Na HK, Choi WH et al (2014) Direct cellular delivery of human proteasomes to delay tau aggregation. Nat Commun 5, 5633 https://doi.org/10.1038/ncomms6633
- Jiang Y, Lee J, Lee JH et al (2016) The arginylation branch of the N-end rule pathway positively regulates cellular autophagic flux and clearance of proteotoxic proteins. Autophagy 12, 2197-2212 https://doi.org/10.1080/15548627.2016.1222991
- Kim JH, Kim E, Choi WH et al (2016) Inhibitory RNA Aptamers of Tau Oligomerization and Their Neuroprotective Roles against Proteotoxic Stress. Mol Pharm 13, 2039-2048 https://doi.org/10.1021/acs.molpharmaceut.6b00165
- Karabiyik C, Lee MJ and Rubinsztein DC (2017) Autophagy impairment in Parkinson's disease. Essays Biochem 61, 711-720 https://doi.org/10.1042/EBC20170023
- Cohen TJ, Friedmann D, Hwang AW, Marmorstein R and Lee VM (2013) The microtubule-associated tau protein has intrinsic acetyltransferase activity. Nat Struct Mol Biol 20, 756-762 https://doi.org/10.1038/nsmb.2555
- Dickey CA, Kamal A, Lundgren K et al (2007) The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J Clin Invest 117, 648-658 https://doi.org/10.1172/JCI29715
- Dickey CA, Dunmore J, Lu B et al (2006) HSP induction mediates selective clearance of tau phosphorylated at proline-directed Ser/Thr sites but not KXGS (MARK) sites. FASEB J 20, 753-755 https://doi.org/10.1096/fj.05-5343fje
- Liu WK, Ksiezak-Reding H and Yen SH (1991) Abnormal tau proteins from Alzheimer's disease brains. Purification and amino acid analysis. J Biol Chem 266, 21723-21727
- David DC, Layfield R, Serpell L, Narain Y, Goedert M and Spillantini MG (2002) Proteasomal degradation of tau protein. J Neurochem 83, 176-185 https://doi.org/10.1046/j.1471-4159.2002.01137.x
- Grune T, Botzen D, Engels M et al (2010) Tau protein degradation is catalyzed by the ATP/ubiquitin-independent 20S proteasome under normal cell conditions. Arch Biochem Biophys 500, 181-188 https://doi.org/10.1016/j.abb.2010.05.008
- Mori H, Kondo J and Ihara Y (1987) Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 235, 1641-1644 https://doi.org/10.1126/science.3029875
- Perry G, Friedman R, Shaw G and Chau V (1987) Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. Proc Natl Acad Sci U S A 84, 3033-3036 https://doi.org/10.1073/pnas.84.9.3033
- Cripps D, Thomas SN, Jeng Y, Yang F, Davies P and Yang AJ (2006) Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-Tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation. J Biol Chem 281, 10825-10838 https://doi.org/10.1074/jbc.M512786200
- Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Titani K and Ihara Y (1993) Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments. Neuron 10, 1151-1160 https://doi.org/10.1016/0896-6273(93)90063-W
- Paine S, Bedford L, Thorpe JR et al (2009) Immunoreactivity to Lys63-linked polyubiquitin is a feature of neurodegeneration. Neurosci Lett 460, 205-208 https://doi.org/10.1016/j.neulet.2009.05.074
- Tan JM, Wong ES, Kirkpatrick DS et al (2008) Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum Mol Genet 17, 431-439 https://doi.org/10.1093/hmg/ddm320
- Tan Z, Sun X, Hou FS et al (2007) Mutant ubiquitin found in Alzheimer's disease causes neuritic beading of mitochondria in association with neuronal degeneration. Cell Death Differ 14, 1721-1732 https://doi.org/10.1038/sj.cdd.4402180
- Keck S, Nitsch R, Grune T and Ullrich O (2003) Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease. J Neurochem 85, 115-122 https://doi.org/10.1046/j.1471-4159.2003.01642.x
- Keller JN, Hanni KB and Markesbery WR (2000) Impaired proteasome function in Alzheimer's disease. J Neurochem 75, 436-439
- Lopez Salon M, Morelli L, Castano EM, Soto EF and Pasquini JM (2000) Defective ubiquitination of cerebral proteins in Alzheimer's disease. J Neurosci Res 62, 302-310 https://doi.org/10.1002/1097-4547(20001015)62:2<302::AID-JNR15>3.0.CO;2-L
- Cardozo C and Michaud C (2002) Proteasome-mediated degradation of tau proteins occurs independently of the chymotrypsin-like activity by a nonprocessive pathway. Arch Biochem Biophys 408, 103-110 https://doi.org/10.1016/S0003-9861(02)00493-9
- Zhang JY, Liu SJ, Li HL and Wang JZ (2005) Microtubule-associated protein tau is a substrate of ATP/Mg(2+)-dependent proteasome protease system. J Neural Transm 112, 547-555 https://doi.org/10.1007/s00702-004-0196-x
- de Vrij FM, Fischer DF, van Leeuwen FW and Hol EM (2004) Protein quality control in Alzheimer's disease by the ubiquitin proteasome system. Prog Neurobiol 74, 249-270 https://doi.org/10.1016/j.pneurobio.2004.10.001
- Lee MJ, Lee JH and Rubinsztein DC (2013) Tau degradation: the ubiquitin-proteasome system versus the autophagy-lysosome system. Prog Neurobiol 105, 49-59 https://doi.org/10.1016/j.pneurobio.2013.03.001
- Petrucelli L, Dickson D, Kehoe K et al (2004) CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum Mol Genet 13, 703-714 https://doi.org/10.1093/hmg/ddh083
- Babu JR, Geetha T and Wooten MW (2005) Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation. J Neurochem 94, 192-203 https://doi.org/10.1111/j.1471-4159.2005.03181.x
- Flach K, Ramminger E, Hilbrich I et al (2014) Axotrophin/MARCH7 acts as an E3 ubiquitin ligase and ubiquitinates tau protein in vitro impairing microtubule binding. Biochim Biophys Acta 1842, 1527-1538 https://doi.org/10.1016/j.bbadis.2014.05.029
- Shimura H, Schwartz D, Gygi SP and Kosik KS (2004) CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J Biol Chem 279, 4869-4876 https://doi.org/10.1074/jbc.M305838200
- Hatakeyama S, Matsumoto M, Kamura T et al (2004) U-box protein carboxyl terminus of Hsc70-interacting protein (CHIP) mediates poly-ubiquitylation preferentially on four-repeat Tau and is involved in neurodegeneration of tauopathy. J Neurochem 91, 299-307 https://doi.org/10.1111/j.1471-4159.2004.02713.x
- Sahara N, Murayama M, Mizoroki T et al (2005) In vivo evidence of CHIP up-regulation attenuating tau aggregation. J Neurochem 94, 1254-1263 https://doi.org/10.1111/j.1471-4159.2005.03272.x
- Joshi V, Amanullah A, Upadhyay A, Mishra R, Kumar A and Mishra A (2016) A Decade of Boon or Burden: What Has the CHIP Ever Done for Cellular Protein Quality Control Mechanism Implicated in Neurodegeneration and Aging? Front Mol Neurosci 9, 93
- Gupta R, Lan M, Mojsilovic-Petrovic J et al (2017) The Proline/Arginine Dipeptide from Hexanucleotide Repeat Expanded C9ORF72 Inhibits the Proteasome. eNeuro 4, e0249-16
- Shin SK, Kim JH, Lee JH et al (2017) Docosahexaenoic acid-mediated protein aggregates may reduce proteasome activity and delay myotube degradation during muscle atrophy in vitro. Exp Mol Med 49, e287 https://doi.org/10.1038/emm.2016.133
- Lee JH, Shin SK, Jiang Y et al (2015) Facilitated Tau Degradation by USP14 Aptamers via Enhanced Proteasome Activity. Sci Rep 5, 10757 https://doi.org/10.1038/srep10757
- Wang Y, Garg S, Mandelkow EM and Mandelkow E (2010) Proteolytic processing of tau. Biochem Soc Trans 38, 955-961 https://doi.org/10.1042/BST0380955